Dapagliflozin for heart failure

Alan Begg

doi:10.1002/pdi.2324

Dapagliflozin for heart failure

Alan Begg (Lead / Corresponding author)

Molecular and Clinical Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	6-7a
Number of pages	3
Journal	Practical Diabetes
Volume	38
Issue number	2
DOIs	https://doi.org/10.1002/pdi.2324
Publication status	Published - 8 Apr 2021

ASJC Scopus subject areas

Internal Medicine
Endocrinology, Diabetes and Metabolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/pdi.2324

Cite this

@article{7e813ca388294d20b9229a238f3b1213,

title = "Dapagliflozin for heart failure",

author = "Alan Begg",

note = "Copyright {\textcopyright} 2021 John Wiley & Sons, Ltd.",

year = "2021",

month = apr,

day = "8",

doi = "10.1002/pdi.2324",

language = "English",

volume = "38",

pages = "6--7a",

journal = "Practical Diabetes",

issn = "2047-2897",

publisher = "Wiley",

number = "2",

}

TY - JOUR

T1 - Dapagliflozin for heart failure

AU - Begg, Alan

PY - 2021/4/8

Y1 - 2021/4/8

UR - http://www.scopus.com/inward/record.url?scp=85104082425&partnerID=8YFLogxK

U2 - 10.1002/pdi.2324

DO - 10.1002/pdi.2324

M3 - Article

AN - SCOPUS:85104082425

SN - 2047-2897

VL - 38

SP - 6-7a

JO - Practical Diabetes

JF - Practical Diabetes

IS - 2

ER -

Dapagliflozin for heart failure

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this